US Patent Issued to GENMAB on July 7 for "Method of treating cancer by administering an antibody which binds to 5T4" (Dutch, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,001, issued on July 7, was assigned to GENMAB A/S (Valby, Denmark).

"Method of treating cancer by administering an antibody which binds to 5T4" was invented by David Satijn (Nieuwegein, Netherlands), Esther C. W. Breij (Driebergen, Netherlands), Bart E. C. G. De Goeij (Utrecht, Netherlands), Patrick Engelberts (Amersfoort, Netherlands), Kristel Kemper (Utrecht, Netherlands), Edward N. Van Den Brink (Halfweg, Netherlands), Rik Rademaker (Utrecht, Netherlands), Dennis Verzijl (Amstelveen, Netherlands), Sjeng Horbach (Oss, Netherlands), Paul Parren (Odijk, Netherlands), Reshma Abdulla Rangwala (Philadelphia), Sri Ghatta (Princeton, N.J.), Ruud Brakenhoff (Amsterdam) and Rieneke Van De...